|
ATG5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05420117080257E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.78120004593552E-09 |
| Normal-vs-Stage2 |
3.73819999954783E-07 |
| Normal-vs-Stage3 |
7.69210251050367E-11 |
| Normal-vs-Stage4 |
7.61524177050887E-12 |
| Stage1-vs-Stage2 |
3.821800E-01 |
| Stage1-vs-Stage3 |
5.188300E-02 |
| Stage1-vs-Stage4 |
4.079000E-03 |
| Stage2-vs-Stage3 |
6.081000E-01 |
| Stage2-vs-Stage4 |
1.070640E-01 |
| Stage3-vs-Stage4 |
1.844390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.20052922737113E-12 |
| Normal-vs-AfricanAmerican |
2.247300E-04 |
| Normal-vs-Asian |
2.7767999999373E-07 |
| Caucasian-vs-AfricanAmerican |
5.023400E-01 |
| Caucasian-vs-Asian |
6.411800E-01 |
| AfricanAmerican-vs-Asian |
7.489800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32379995854137E-10 |
| Normal-vs-Female |
9.72120162145984E-11 |
| Male-vs-Female |
2.893800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.02519999997963E-07 |
| Normal-vs-Age(41-60Yrs) |
2.30280239321701E-11 |
| Normal-vs-Age(61-80Yrs) |
1.87060367196068E-11 |
| Normal-vs-Age(81-100Yrs) |
3.039900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.047800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.099600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.773550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.732400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.180200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.689600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.492100E-02 |
| Classical-VS-Follicular |
6.631600E-01 |
| Classical-VS-Other |
6.673800E-01 |
| Classical-VS-Normal |
2.62249999494202E-10 |
| Tall-VS-Follicular |
1.791600E-01 |
| Tall-VS-Other |
6.555200E-01 |
| Tall-VS-Normal |
4.14599999887244E-08 |
| Follicular-VS-Other |
8.336600E-01 |
| Follicular-VS-Normal |
5.43480000003704E-07 |
| Other-VS-Normal |
9.543800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44669998203284E-09 |
| Normal-vs-N1 |
1.54879997715796E-10 |
| N0-vs-N1 |
4.118300E-02 |
|
|
